| Annual Financials | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 30 | 23 | 30 | 36 | 40 | 51 | 73 | 0 |
| Expenses | 30 | 22 | 27 | 28 | 32 | 41 | 60 | 0 |
| EBITDA | 0 | 0 | 3 | 8 | 9 | 10 | 13 | 0 |
| Operating Profit % | 1 % | 1 % | 10 % | 22 % | 21 % | 20 % | 17 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 3 | 7 | 8 | 10 | 12 | 0 |
| Tax | 0 | 0 | 1 | 2 | 2 | 2 | 3 | 0 |
| Net Profit | 0 | 0 | 2 | 5 | 6 | 7 | 9 | 0 |
| EPS in ₹ | 1.77 | 0.88 | 42.54 | 6.72 | 5.36 | 6.26 | 6.57 | 0.00 |
Shelter Pharma
Shelter Pharma
29.50
0.00
(0.00%)
Market Cap
49.70 Cr
PE Ratio
5.50
Volume
0.00
Day High - Low
- - -
52W High-Low
50.00 - 26.50
Key Fundamentals
Market Cap
49.70 Cr
EPS
6.57
PE Ratio
5.50
PB Ratio
0.68
Book Value
43.16
EBITDA
12.72
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
16.94
Debt to Equity
0.02
Actual
Company News
View All News
Shelter Pharma commences export order dispatch
Jun 08, 2026
Jun 08, 2026Shelter Pharma began dispatching an export order worth USD 141,600 for Joemega Capsules to Sudan. Manufacturing is complete, with USD 118,634 worth of goods already shipped.
Shelter Pharma schedules H2, FY26 investor callJun 05, 2026
Jun 05, 2026Shelter Pharma Limited will hold an investor conference call on June 10, 2026, to discuss audited financial results for H2 and FY26. The meeting is scheduled for 3:30 PM IST via Zoho Meeting.
Shelter Pharma Secures GMP Cert for Ayurvedic Plant Till 2030Jun 03, 2026
Shelter Pharma has received GMP certification for its Ayurvedic manufacturing plant, with the certification remaining valid until 2030.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,879.00 | #1 4,50,835.04 | 39.08 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 66.93 | |
6,719.50 | 1,78,381.61 | 69.79 | 10,560.00 | 8.73 | 2,520 | 13.44 | 55.02 | |
4,494.70 | 1,52,121.07 | 71.28 | 13,886.20 | 20.34 | 2,138 | -26.91 | 55.98 | |
1,444.50 | 1,16,683.92 | 30.07 | 29,044.60 | 2.24 | 3,870 | -55.32 | 65.05 | |
1,361.10 | 1,13,603.26 | 26.67 | 33,593.30 | -0.44 | 3,998 | -86.05 | 64.53 | |
1,111.80 | 1,11,873.10 | 21.58 | 26,719.70 | 13.65 | 5,242 | 7.82 | 61.12 | |
2,375.10 | 1,08,552.33 | #1 20.22 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 63.99 | |
2,501.10 | 1,03,246.68 | 52.76 | 14,277.60 | 12.03 | 1,750 | 31.75 | 59.95 | |
1,552.00 | 90,140.41 | 25.36 | 33,384.70 | 3.21 | 3,376 | 1.99 | 63.83 | |
1,454.20 | 78,505.94 | 88.23 | 6,867.80 | #1 22.01 | 890 | 21.18 | 65.69 |
Growth Rate
Revenue Growth
44.24 %
Net Income Growth
25.69 %
Cash Flow Change
379.59 %
ROE
-2.14 %
ROCE
-1.88 %
EBITDA Margin (Avg.)
-12.53 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 11 | 10 | 13 | 21 | 38 | 48 | 84 |
| Fixed Assets | 2 | 2 | 2 | 2 | 4 | 6 | 7 |
| Current Assets | 8 | 8 | 10 | 19 | 30 | 33 | 55 |
| Capital Work in Progress | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 24 |
| Other Assets | 9 | 9 | 11 | 20 | 34 | 42 | 0 |
| Total Equity & Liabilities | 11 | 10 | 13 | 21 | 38 | 48 | 84 |
| Current Liabilities | 4 | 3 | 4 | 6 | 2 | 5 | 7 |
| Non Current Liabilities | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Total Equity | 7 | 7 | 9 | 15 | 36 | 43 | 73 |
| Reserve & Surplus | 7 | 7 | 8 | 7 | 24 | 31 | 56 |
| Share Capital | 1 | 1 | 1 | 8 | 12 | 12 | 17 |
Cash Flow
| Cash Flow | 2017 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 0 | -0 | 0 | 5 | -2 |
| Investing Activities | 0 | 0 | 0 | -1 | 0 | -4 | -7 |
| Operating Activities | 0 | -0 | -0 | 1 | 0 | -2 | 6 |
| Financing Activities | 0 | 0 | 1 | 0 | 0 | 11 | 0 |
Share Holding
| % Holding | Aug 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Aug 2025 | Sept 2025 | Oct 2025 | Nov 2025 | Mar 2026 | May 2026 |
| Promoter | 56.89 % | 56.89 % | 56.89 % | 54.97 % | 52.32 % | 52.32 % | 52.32 % | 46.98 % | 47.19 % | 44.38 % | 44.38 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 29.22 % | 30.18 % | 30.23 % | 40.12 % | 43.24 % | 42.69 % | 42.82 % | 48.66 % | 49.32 % | 51.46 % | 51.46 % |
| Others | 13.89 % | 12.93 % | 12.88 % | 4.91 % | 4.44 % | 4.99 % | 4.86 % | 4.36 % | 3.49 % | 4.16 % | 4.16 % |
| No of Share Holders | 1,165 | 836 | 868 | 1,119 | 1,153 | 1,109 | 1,094 | 1,094 | 1,093 | 1,071 | 1,076 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 23 Sept 2024 |  Dividend | ₹ 0.33 /share | 23 Sept 2024 | 46.97 | 48.21 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 46.97 | 47.50 |
| 30 Oct 2024 |  Quarterly Result Announcement | NA | 30 Oct 2024 | 46.88 | 47.15 |
| 29 May 2025 | Quarterly Result Announcement | NA | 29 May 2025 | 38.00 | 39.50 |
| 23 Jul 2025 |  Extraordinary General Meeting | NA | 23 Jul 2025 | 39.60 | 43.97 |
| 23 Sept 2025 | Dividend | ₹ 0.35 /share | 23 Sept 2025 | 45.00 | 43.27 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 45.00 | 44.00 |
| 10 Nov 2025 | Quarterly Result Announcement | NA | 10 Nov 2025 | 41.50 | 41.86 |
| 28 May 2026 | Quarterly Result Announcement | NA | 28 May 2026 | 31.00 | 30.00 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation7 days ago
7 days agoCorrigendum To Intimation Of H2 FY2026 Investor Conference Call8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
9 days agoCorrigendum To Intimation Of H2 FY2026 Investor Conference Call Withdrawal Of Scheduled MeetingJun 08, 2026
Jun 08, 2026Intimation Under Regulation 30 Of SEBI LODR (Regulation) 2015-
Completion And Commencement Of Dispatch Of Export OrderJun 08, 2026
Jun 08, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 05, 2026
Jun 05, 2026Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015- Receipt Of Good Manufacturing Practices CertificateJun 03, 2026
Jun 03, 2026Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015-Receipt Of Renewal Manufacturing LicenceJun 02, 2026
Jun 02, 2026Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 28, 2026
May 28, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 28, 2026
May 28, 2026Outcome Of The Board Meeting And Submission Of The
Audited Standalone Financial Results For The Half Year And
Year Ended March 31 2026May 28, 2026
May 28, 2026Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of The Audited Standalone Financial Results For The Half Year And
Year Ended March 31 2026.May 28, 2026
May 28, 2026Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 28Th May 2026May 22, 2026
May 22, 2026Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015-Continuous Positive Customer Feedback On Company ProductsMay 19, 2026
May 19, 2026Intimation Under Regulation 30 Of SEBI ( LODR ) Regulations 2015 - Participation In Iphex 2026 International Pharmaceutical ExihibitionMay 18, 2026
May 18, 2026Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015
Receipt Work Order Pursuant To Tender Process.May 15, 2026
May 15, 2026Intimation Under Regulation 30 For Successfully Conducted A CME Programme In Patna Bihar On 11Th May 2026May 13, 2026
May 13, 2026Intimation Under Regulation 30 Of SEBI (LODR) Regulation 2015- New Product Launch.May 11, 2026
May 11, 2026Announcement under Regulation 30 (LODR)-Conversion of SecuritiesMay 05, 2026
May 05, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday May 05 2026 For Conversion Of 111000 Warrants Into 111000 Equity Shares Of Face Value Of Rs. 10/-May 05, 2026
May 05, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMay 05, 2026
May 05, 2026Announcement under Regulation 30 (LODR)-Conversion of SecuritiesMay 01, 2026
May 01, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday May 01 2026.May 01, 2026
May 01, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 30, 2026
Apr 30, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 29, 2026
Apr 29, 2026Intimation Under Regulation 30 Update On Export OperationApr 16, 2026
Apr 16, 2026Intimation Under Regulation 30 Hired Senior Management Personnel In Line With Business Expansion PlansApr 15, 2026
Apr 15, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceApr 14, 2026
Apr 14, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2026
Apr 14, 2026Intimation Under Regulation 30 Of SEBI( Listing Obligations And Disclousure Requirements ) Regulation 2015 For Hiring Of Senior Management Personnel In Line With Business Expansion PlansApr 07, 2026
Apr 07, 2026Intimation Under Regulation 30 Of SEBI ( Listing Obligation And Disclousure Requirements ) Regulation 2015 Reciept Of Negotiation Meeting Intimation From Verka Dairies ( Punjab State Co Operative Milk Producers Federation Limited )Apr 06, 2026
Apr 06, 2026Intimation Under Regulation 30 Of SEBI ( Listing Obligations And Disclousures Requirements) Regulations 2015 Positive Customer Feedback On Companies ProductsApr 02, 2026
Apr 02, 2026Intimation Under Regulation 30 Of SEBI ( LODR ) New Product Now Available In The MarketApr 01, 2026
Apr 01, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026Intimitation Under Regulation 30 Third Party Food Safety Audit Under FSSAI Regulatory FrameworkMar 18, 2026
Mar 18, 2026Intimation Under Regulation 30 Of SEBI ( Listing Obligation And Disclousure Requirements) Regulation 2015 - Appointment Of Investor Relation And Public Relation AuthorityMar 13, 2026
Mar 13, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 12, 2026
Mar 12, 2026Announcement under Regulation 30 (LODR)-Conversion of SecuritiesMar 07, 2026
Mar 07, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday March 07 2026Mar 07, 2026
Mar 07, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 02, 2026
Feb 02, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJan 27, 2026
Jan 27, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJan 23, 2026
Jan 23, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2026
Jan 16, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderDec 16, 2025
Dec 16, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 15, 2025
Dec 15, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderDec 12, 2025
Dec 12, 2025Announcement under Regulation 30 (LODR)-Conversion of SecuritiesNov 17, 2025
Nov 17, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday November 17 2025 Considered And Approved The Conversion Of 735000 Warrants Into 735000 Equity Shares Of Face Value Of Rs. 10/- (Rupees Ten Only)
Nov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-AllotmentNov 15, 2025
Nov 15, 2025Technical Indicators
RSI(14)
Neutral 47.24
ATR(14)
Less Volatile 1.23
STOCH(9,6)
Neutral 27.15
STOCH RSI(14)
Neutral 62.90
MACD(12,26)
Bearish -0.05
ADX(14)
Weak Trend 12.20
UO(9)
Bearish 38.40
ROC(12)
Uptrend And Accelerating 0.82
WillR(14)
Neutral -55.36
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
